ORIGINAL ARTICLE

Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases

H H J Backus¹, C J Van Groeningen¹, W Vos², D F Dukers², E Bloemena², D Wouters¹, H M Pinedo¹ and G J Peters¹

¹ Department of Medical Oncology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
² Department of Pathology, VU University Medical Center

Correspondence to:
Correspondence to:
Dr G J Peters, Department of Medical Oncology, VU University Medical Center (VUMC), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands;
gj.peters{at}vumc.nl

Aims: Tumour cell growth results from a disturbance in the balance between the rate of proliferation and cell death. In this study, proteins involved in the regulation of cell cycle arrest and apoptosis were studied as possible factors responsible for uncontrolled cell growth in colorectal cancer.

Methods: The expression of proteins involved in these processes was investigated in 48 metastases from patients with colorectal cancer and compared with eight normal colon mucosa samples and 14 primary tumours. Both primary tumours and metastases were obtained from eight patients. The expression of thymidylate synthase (TS), p53, retinoblastoma protein (Rb), Fas receptor, Fas ligand, bcl-2, mcl-1, bax, and bcl-x was measured using immunohistochemistry. Proliferation was determined by Ki67 staining, whereas apoptosis was assessed by M30 immunostaining, which recognises cleaved cytokeratin 18.

Results: In the limited number of cases in which paired comparisons were possible, the expression of TS and Ki67 was significantly higher in metastases than in the matched primary tumour samples (p = 0.014 and 0.016, respectively), whereas Rb expression was lower in metastases than in primary tumours (p = 0.024). Fas receptor expression was high in normal mucosa but absent in primary tumours and metastases, whereas the opposite was seen for p53. The expression of bax, mcl-1, and bcl-x in normal mucosa was more apical than that seen in malignant cells, where a more diffuse expression pattern was seen (p < 0.04). Apoptosis was more abundant in primary tumours than in metastases.

Conclusions: These results demonstrate that proliferation and apoptosis are disturbed during colorectal cancer progression, and this is accompanied by loss of Rb and Fas expression, the accumulation of p53 and TS, and changes in the expression patterns of bax, mcl-1, and bcl-xl.

Keywords: normal mucosa; colorectal tumours; cell cycle; apoptosis

Abbreviations: CTL, cytotoxic lymphocyte; 5FU, 5-fluorouracil; Rb, retinoblastoma protein; TS, thymidylate synthase

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Badvie, S, Hanna-Morris, A, Andreyev, H J N, Cohen, P, Saini, S, Allen-Mersh, T G (2006). A "field change" of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma. J. Clin. Pathol. 59: 942-946 [Abstract] [Full Text]  
• Smorenburg, C. H., Peters, G. J., van Groeningen, C. J., Noordhuis, P., Smid, K., van Riel, A. M. G. H., Dercksen, W., Pinedo, H. M., Giaccone, G. (2006). Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase. Ann Oncol 17: 35-42 [Abstract] [Full Text]  
• Wong, S. C. C., Lo, S. F. E., Cheung, M. T., Ng, K. O. E., Tse, C. W., Lai, B. S. P., Lee, K. C., Lo, Y. M. D. (2004). Quantification of Plasma {beta}-Catenin mRNA in Colorectal Cancer and Adenoma Patients. Clin. Cancer Res. 10: 1613-1617 [Abstract] [Full Text]  
• Choti, M. A. (2004). Editorial: In Search of Better Outcome Predictors for Patients Following Resection of Colorectal Metastases. Ann. Surg. Oncol. 11: 7-8 [Full Text]  
• van Grieken, N C T, Meijer, G A, zur Hausen, A, Meuwissen, S G M, Baak, J P A, Kuipers, E J (2003). Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia. J. Clin. Pathol. 56: 358-361 [Abstract] [Full Text]